WallStreetZenWallStreetZen

NASDAQ: CORT
Corcept Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for CORT

Based on 3 analysts offering 12 month price targets for Corcept Therapeutics Inc.
Min Forecast
$28.00+19.15%
Avg Forecast
$36.00+53.19%
Max Forecast
$42.00+78.72%

Should I buy or sell CORT stock?

Based on 3 analysts offering ratings for Corcept Therapeutics Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CORT stock forecasts and price targets.

CORT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-16Find Out Why
lockedlocked$00.00+00.00%2024-01-02
lockedlocked$00.00+00.00%2023-12-13

1 of 1

Forecast return on equity

Is CORT forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.47%

Forecast return on assets

Is CORT forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CORT revenue forecast

What is CORT's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$606.8M+25.8%
Avg 2 year Forecast
$644.6M+33.63%
Avg 3 year Forecast
$787.0M+63.15%
CORT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CORT earnings growth forecast

How is CORT forecast to perform vs Biotechnology companies and vs the US market?
Company
29.98%
Industry
6.72%
Market
22.38%
CORT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CORT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CORT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CORT revenue growth forecast

How is CORT forecast to perform vs Biotechnology companies and vs the US market?
Company
16.21%
Industry
46.57%
Market
10.79%
CORT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CORT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CORT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CORT$23.50$36.00+53.19%Strong Buy
KROS$67.50$73.00+8.15%Strong Buy
MOR$17.60$11.29-35.85%Strong Buy
GLPG$35.11$44.00+25.32%Hold
KYMR$42.70$38.29-10.34%Buy

Corcept Therapeutics Stock Forecast FAQ

Is Corcept Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CORT) stock is to Strong Buy CORT stock.

Out of 3 analysts, 2 (66.67%) are recommending CORT as a Strong Buy, 1 (33.33%) are recommending CORT as a Buy, 0 (0%) are recommending CORT as a Hold, 0 (0%) are recommending CORT as a Sell, and 0 (0%) are recommending CORT as a Strong Sell.

If you're new to stock investing, here's how to buy Corcept Therapeutics stock.

What is CORT's revenue growth forecast for 2024-2026?

(NASDAQ: CORT) Corcept Therapeutics's forecast annual revenue growth rate of 16.21% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 46.57%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.79%.

Corcept Therapeutics's revenue in 2024 is $482,375,000.On average, 4 Wall Street analysts forecast CORT's revenue for 2024 to be $62,816,938,973, with the lowest CORT revenue forecast at $62,120,784,539, and the highest CORT revenue forecast at $63,801,906,920. On average, 4 Wall Street analysts forecast CORT's revenue for 2025 to be $66,728,343,479, with the lowest CORT revenue forecast at $56,972,864,834, and the highest CORT revenue forecast at $73,287,205,182.

In 2026, CORT is forecast to generate $81,469,737,117 in revenue, with the lowest revenue forecast at $81,357,420,751 and the highest revenue forecast at $81,582,053,483.

What is CORT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CORT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CORT's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CORT price target, the average CORT price target is $36.00, with the highest CORT stock price forecast at $42.00 and the lowest CORT stock price forecast at $28.00.

On average, Wall Street analysts predict that Corcept Therapeutics's share price could reach $36.00 by Feb 16, 2025. The average Corcept Therapeutics stock price prediction forecasts a potential upside of 53.19% from the current CORT share price of $23.50.

What is CORT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CORT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.